IMPLICATIONS FOR PATIENT CARE:68Ga-exendin4 PET may enable quantification of longitudinal changes in pancreatic GLP1R during the development of T2D, as well as target occupancy in drug development studies. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.